-DOCSTART- -X- O
The -X- _ O
repeating -X- _ O
unit -X- _ O
of -X- _ O
the -X- _ O
C. -X- _ B-Patient
difficile -X- _ I-Patient
Toxin -X- _ I-Patient
A -X- _ I-Patient
( -X- _ I-Patient
rARU -X- _ I-Patient
, -X- _ O
also -X- _ O
known -X- _ O
as -X- _ O
CROPS -X- _ O
[ -X- _ O
combined -X- _ O
repetitive -X- _ O
oligopeptides -X- _ O
] -X- _ O
) -X- _ O
C-terminal -X- _ O
region -X- _ O
, -X- _ O
was -X- _ O
shown -X- _ O
to -X- _ O
elicit -X- _ O
protective -X- _ O
immunity -X- _ O
against -X- _ O
C. -X- _ O
difficile -X- _ O
and -X- _ O
is -X- _ O
under -X- _ O
consideration -X- _ O
as -X- _ O
a -X- _ O
possible -X- _ O
vaccine -X- _ O
against -X- _ O
this -X- _ O
pathogen. -X- _ O
However -X- _ O
, -X- _ O
expression -X- _ O
of -X- _ O
recombinant -X- _ B-Intervention
rARU -X- _ I-Intervention
in -X- _ I-Intervention
E. -X- _ I-Intervention
coli -X- _ I-Intervention
using -X- _ O
the -X- _ O
standard -X- _ O
vaccine -X- _ O
production -X- _ O
process -X- _ O
was -X- _ O
very -X- _ O
low. -X- _ O
Transcriptome -X- _ O
and -X- _ O
proteome -X- _ O
analyses -X- _ O
showed -X- _ O
that -X- _ O
at -X- _ O
restricted -X- _ O
dissolved -X- _ O
oxygen -X- _ O
( -X- _ O
DO -X- _ O
) -X- _ O
the -X- _ O
numbers -X- _ O
of -X- _ O
differentially -X- _ O
expressed -X- _ O
genes -X- _ O
( -X- _ O
DEGs -X- _ O
) -X- _ O
was -X- _ O
2.5-times -X- _ O
lower -X- _ O
than -X- _ O
those -X- _ O
expressed -X- _ O
at -X- _ O
unrestricted -X- _ O
oxygen. -X- _ O
Additionally -X- _ O
, -X- _ O
a -X- _ O
7.4-times -X- _ O
smaller -X- _ O
number -X- _ O
of -X- _ O
ribosome -X- _ O
formation -X- _ O
genes -X- _ O
( -X- _ O
needed -X- _ O
for -X- _ O
translation -X- _ O
) -X- _ O
were -X- _ O
down-regulated -X- _ O
as -X- _ O
compared -X- _ O
with -X- _ O
unrestricted -X- _ O
DO. -X- _ O
Higher -X- _ O
rARU -X- _ O
expression -X- _ O
at -X- _ O
restricted -X- _ O
DO -X- _ O
was -X- _ O
associated -X- _ O
with -X- _ O
up-regulation -X- _ O
of -X- _ O
24 -X- _ O
heat -X- _ O
shock -X- _ O
chaperones -X- _ O
involved -X- _ O
in -X- _ O
protein -X- _ O
folding -X- _ O
and -X- _ O
with -X- _ O
the -X- _ O
up-regulation -X- _ O
of -X- _ O
the -X- _ O
global -X- _ O
regulator -X- _ O
RNA -X- _ O
chaperone -X- _ O
hfq. -X- _ O
Cellular -X- _ O
stress -X- _ O
response -X- _ O
leading -X- _ O
to -X- _ O
down-regulation -X- _ O
of -X- _ O
transcription -X- _ O
, -X- _ O
translation -X- _ O
, -X- _ O
and -X- _ O
energy -X- _ O
generating -X- _ O
pathways -X- _ O
at -X- _ O
unrestricted -X- _ O
DO -X- _ O
were -X- _ O
associated -X- _ O
with -X- _ O
lower -X- _ O
rARU -X- _ O
expression. -X- _ O
Investigation -X- _ O
of -X- _ O
the -X- _ O
C. -X- _ O
difficile -X- _ O
DNA -X- _ O
sequence -X- _ O
revealed -X- _ O
the -X- _ O
presence -X- _ O
of -X- _ O
cell -X- _ O
wall -X- _ O
binding -X- _ O
profiles -X- _ O
, -X- _ O
which -X- _ O
based -X- _ O
on -X- _ O
structural -X- _ O
similarity -X- _ O
prediction -X- _ O
by -X- _ O
BLASTp -X- _ O
, -X- _ O
can -X- _ O
possibly -X- _ O
interact -X- _ O
with -X- _ O
cellular -X- _ O
proteins -X- _ O
of -X- _ O
E. -X- _ O
coli -X- _ O
such -X- _ O
as -X- _ O
the -X- _ O
transcriptional -X- _ O
repressor -X- _ O
ulaR -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
ankyrins -X- _ O
repeat -X- _ O
proteins. -X- _ O
At -X- _ O
restricted -X- _ O
DO -X- _ O
, -X- _ O
rARU -X- _ O
mRNA -X- _ O
was -X- _ O
5-fold -X- _ O
higher -X- _ O
and -X- _ O
the -X- _ O
protein -X- _ O
expression -X- _ O
27-fold -X- _ O
higher -X- _ O
compared -X- _ O
with -X- _ O
unrestricted -X- _ O
DO. -X- _ O
The -X- _ O
report -X- _ O
shows -X- _ O
a -X- _ O
strategy -X- _ O
for -X- _ O
improved -X- _ O
production -X- _ O
of -X- _ O
C. -X- _ B-Comparison
difficile -X- _ I-Comparison
vaccine -X- _ I-Comparison
candidate -X- _ I-Comparison
in -X- _ O
E. -X- _ O
coli -X- _ O
by -X- _ O
using -X- _ O
restricted -X- _ O
DO -X- _ O
growth. -X- _ O
This -X- _ O
strategy -X- _ O
could -X- _ O
improve -X- _ O
the -X- _ O
expression -X- _ O
of -X- _ O
recombinant -X- _ B-Outcome
proteins -X- _ I-Outcome
from -X- _ I-Outcome
anaerobic -X- _ I-Outcome
origin -X- _ I-Outcome
or -X- _ I-Outcome
those -X- _ I-Outcome
with -X- _ I-Outcome
cell -X- _ I-Outcome
wall -X- _ I-Outcome
binding -X- _ I-Outcome
profiles -X- _ I-Outcome
. -X- _ O

